Skip to content
WeighLab
Menu
Ranked #32 · Grade B−

GOAL.MD review

GOAL.MD is a St. Louis-based telehealth platform offering compounded semaglutide alongside brand-name bridges to Ozempic, Wegovy, and Zepbound. Its standout is a manual-renewal model — no auto-billing

Visit GOAL.MD Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$179/mo
Tirzepatide
$249/mo (starting dose, compounded)
Coverage
All 50 states
Brand-name
Yes

Semaglutide · modeled / year

$2,148

Tirzepatide · modeled / year

$2,988

The Index scorecard

GOAL.MD scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month83/100
Price Transparency94/100
Nationwide Access86/100
Formulation Options90/100
Clinical Oversight70/100
Contract Flexibility55/100

Where the value is

  • Transparent dose-tiered pricing on brand pens
  • LegitScript Certified
  • Manual-renewal model — no surprise auto-billing
  • Free nutrition coach included
  • BBB A+ rating since 2021

The tradeoffs

  • No named compounding pharmacy partner
  • Co-founder and chief physician has a 2016 federal guilty plea for distributing misbranded HGH and a (reinstated) license revocation
  • No URAC or PCAB pharmacy accreditation

The bottom line

Best for: Cost-first shoppers who want manual-renewal billing with dose-tiered brand-name pricing transparency. GOAL.MD is a St. Louis-based telehealth platform offering compounded semaglutide alongside brand-name bridges to Ozempic, Wegovy, and Zepbound. Its standout is a manual-renewal model — no auto-billing

Ranked #32 of 492 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 491 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to GOAL.MD.

The 24 programs nearest this one

Pricing, states and verification reflect GOAL.MD's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on GOAL.MD's site. Not medical advice; see our disclosure.

← Back to the value leaderboard